The major glycosylation alterations in gliomas include aberrant N-linked glycosylation and O-linked glycosylation on integrins and receptor tyrosine kinase, as well as aberrant glycoprotein sialylation. This evidence concerns the gene NTRK1 and central nervous system cancer.